OrbiMed Advisors Israel II Ltd — SEC insider filings

SEC reporting owner CIK 1682093. 21 insider filings on record with FilingPulse; latest filed 2026-09-30.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2020-09-17 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ADARx Pharmaceuticals, Inc. (ADRX)Director, 10% owner23 legs · 950,000 sh · $16,150,000—16
Adicet Bio, Inc. (ACET)10% owner79 legs · 9,000,000 sh · $14,328,7504 legs · 104,658 sh · $674,8478
Upstream Bio, Inc. (UPB)Director, 10% owner12 legs · 825,000 sh · $14,025,000—6
Galecto, Inc. (GLTO)10% owner82 legs · 733,333 sh · $10,999,99536 legs · 1,504,628 sh · $2,298,56115
LogicBio Therapeutics, Inc. (LOGC)Director, 10% owner13 legs · 1,481,482 sh · $8,888,892——
89bio, Inc. (ETNB)10% owner2—6 legs · 345,573 sh · $8,292,384—

Insider filings — OrbiMed Advisors Israel II Ltd

FiledFormIssuerReported transactionsSource
2026-09-304ADARx Pharmaceuticals, Inc. (ADRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P., OrbiMed Genesis GP LLC
Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 moreEDGAR
2026-09-243ADARx Pharmaceuticals, Inc. (ADRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P.
Holdings only — no transactions reportedEDGAR
2026-04-094Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52EDGAR
2025-10-104Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1EDGAR
2024-10-174Upstream Bio, Inc. (UPB)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Israel GP II, L.P.
Conversion (C): 721,956 · Purchase (P): 165,000 @ $17 · Conversion (C): 2,887,833 · Purchase (P): 660,000 @ $17 · Conversion (C): 524,500 (derivative) · Conversion (C): 2,098,000 (derivative) · +2 moreEDGAR
2024-01-264Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40EDGAR
2023-08-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 38,327 @ $0.75 · Sale (S): 248,819 @ $0.75 · Sale (S): 535,534 @ $0.75EDGAR
2023-08-024Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 26,622 @ $3 · Sale (S): 29,700 @ $3 · Sale (S): 153,078 @ $3EDGAR
2023-07-274Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 7,800 @ $2.92 · Sale (S): 4,700 @ $2.92 · Sale (S): 26,700 @ $2.92EDGAR
2023-07-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 9,800 @ $2.40 · Sale (S): 52,800 @ $2.40 · Sale (S): 132,100 @ $2.40EDGAR
2023-06-294Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership, Chimovits Erez
Purchase (P): 125,000 @ $2.09 · Purchase (P): 250,000 @ $2.09 · Purchase (P): 442,000 @ $2.09 · Purchase (P): 58,000 @ $2.09EDGAR
2023-04-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · Sale (S): 2,091 @ $1.86 · Sale (S): 11,245 @ $1.86 · Sale (S): 28,110 @ $1.86 · +3 moreEDGAR
2023-04-124Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 2,584 @ $1.79 · Sale (S): 13,899 @ $1.79 · Sale (S): 34,745 @ $1.79 · Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · +3 moreEDGAR
2023-04-074Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC
Sale (S): 4,687 @ $2.18 · Sale (S): 25,220 @ $2.18 · Sale (S): 63,058 @ $2.18 · Sale (S): 487 @ $2 · Sale (S): 2,620 @ $2 · Sale (S): 6,558 @ $2EDGAR
2022-01-27489bio, Inc. (ETNB)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P.
Sale (S): 24,546 @ $8.40 · Sale (S): 24,545 @ $8.40 · Sale (S): 10,742 @ $8.38 · Sale (S): 10,740 @ $8.38EDGAR
2021-12-144Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Grant/award (A): 214,285 @ $14EDGAR
2021-02-184Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Grant/award (A): 420,299 @ $13 · Grant/award (A): 104,050 @ $13EDGAR
2020-11-044Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Conversion (C): 2,055,824 · Conversion (C): 822,311 · Conversion (C): 191,787 · Purchase (P): 523,833 @ $15 · Purchase (P): 209,500 @ $15 · Grant/award (A): 148,395 (derivative) @ $27.11 · +11 moreEDGAR
2020-10-054LogicBio Therapeutics, Inc. (LOGC)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Genesis GP LLC
Purchase (P): 545,974 @ $6 · Purchase (P): 639,212 @ $6 · Purchase (P): 296,296 @ $6EDGAR
2020-09-23489bio, Inc. (ETNB)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P.
Sale (S): 137,500 @ $28 · Sale (S): 137,500 @ $28EDGAR
2020-09-174Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Grant/award (A): 4,822,960 · Grant/award (A): 902,885 · Grant/award (A): 292,607 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1682093 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs